|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 471/04 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 498/16 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) |
| (11) | Patento numeris | 3615539 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18792253.9 |
| Europos patento paraiškos padavimo data | 2018-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-03-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2018/084674 |
| Data | 2018-04-26 |
| (87) | Numeris | WO 2018/196823 |
| Data | 2018-11-01 |
| (30) | Numeris | Data | Šalis |
| 201710287322 | 2017-04-27 | CN |
| (72) |
LI, Lixin , CN
GUAN, Huiping , CN
|
| (73) |
Birdie Biopharmaceuticals, Inc. ,
Sertus Chambers
P.O. Box 2547
Cassia Court
Camana Bay, Grand Cayman,
KY
|
| (54) | 2-AMINO-QUINOLINE DERIVATIVES |
| 2-AMINO-QUINOLINE DERIVATIVES |